Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Author index

Page Path
HOME > Browse articles > Author index
Search
Jonathan Rock 1 Article
Appendiceal Neuroendocrine, Goblet and Signet-Ring Cell Tumors: A Spectrum of Diseases with Different Patterns of Presentation and Outcome
Walid Shaib, Kavya Krishna, Sungjin Kim, Michael Goodman, Jonathan Rock, Zhengjia Chen, Edith Brutcher, Charles III Staley, Shishir K. Maithel, Samih Abdel-Missih, Bassel F. El-Rayes, Tanios Bekaii-Saab
Cancer Res Treat. 2016;48(2):596-604.   Published online June 5, 2015
DOI: https://doi.org/10.4143/crt.2015.029
AbstractAbstract PDFPubReaderePub
Purpose
Appendiceal tumors are a heterogeneous group of diseases that include typical neuroendocrine tumors (TNET), goblet cell carcinoids (GCC), and atypical GCC. Atypical GCC are classified into signet-ring cell cancers (SRCC) and poorly differentiated appendiceal adenocarcinoids. The prognosis and management of these diseases is unclear because there are no prospective studies. The aim of this study is to assess the characteristics and outcome of appendiceal TNET, GCC, and SRCC patients.
Materials and Methods
Appendiceal TNET, GCC, and SRCC patients diagnosed between 1973 and 2011 were identified in the Surveillance Epidemiology and End Results (SEER) database. Demographics, type of surgery, and clinicopathologic characteristics were collected. Survival functions were estimated by the Kaplan-Meier method, and log-rank test was used to assess the difference in overall survival (OS) among the three histologies.
Results
The SEER database yielded 1,021 TNET patients, 1,582 with GCC, and 534 SRCC patients. TNET presented at a younger age (p < 0.001). Patients with SRCC presented with advanced stage disease (p < 0.001). The median OS (mOS) for GCC and TNET patients was not reached; mOS for SRCC was 24 months. Multivariate analysis stratified for stage revealed significantly longer survival for TNET and GCC than SRCC (p < 0.001).
Conclusion
This is the largest report to date for appendiceal neuroendocrine tumor patients, suggesting a spectrum of diseases with different characteristics and outcomes. In this report, we present a treatment approach for this complex spectrum of disease, based on the experience of Ohio State and Emory Universities investigators.

Citations

Citations to this article as recorded by  
  • Postoperative 68Ga‐DOTATATE positron emission tomography has a low yield in incidental appendiceal neuroendocrine tumours
    Emilie Pauvert, George Larcos
    ANZ Journal of Surgery.2024;[Epub]     CrossRef
  • Appendiceal goblet cell carcinoma has marginal advantages from perioperative chemotherapy: a population-based study with an entropy balancing analysis
    Claudio Ricci, Davide Campana, Carlo Ingaldi, Giuseppe Lamberti, Laura Alberici, Valentina Tateo, Giovanni Castagna, Gianluca Ricco, Fulvio Calderaro, Deborah Malvi, Francesca Rosini, Riccardo Casadei
    Langenbeck's Archives of Surgery.2023;[Epub]     CrossRef
  • Appendixneoplasien
    Safak Gül-Klein, Alexander Arnold, Christian Oberender, Matylda Zofia Kuzinska, Miguel Enrique Alberto Vilchez, Martina T. Mogl, Beate Rau
    coloproctology.2023; 45(2): 139.     CrossRef
  • Collision Tumor of the Appendix
    Álvaro Morillo Cox, Tatiana Fernandez Trokhimtchouk, Luis F Flores, Diego Viteri, Olmedo Mancero, Estefanie S Otanez
    Cureus.2023;[Epub]     CrossRef
  • The Promise of Epigenetics Research in the Treatment of Appendiceal Neoplasms
    Luisa Ladel, Wan Ying Tan, Thanushiya Jeyakanthan, Bethsebie Sailo, Anup Sharma, Nita Ahuja
    Cells.2023; 12(15): 1962.     CrossRef
  • Incidental Detection and Management of a Neuroendocrine Carcinoid Tumor of the Appendix in a Young Male Patient
    Anjani H Turaga
    Cureus.2023;[Epub]     CrossRef
  • An International Registry of Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Frederic Mercier, Guillaume Passot, Pierre‐Emmanuel Bonnot, Peter Cashin, Wim Ceelen, Evelyne Decullier, Laurent Villeneuve, Thomas Walter, Edward A. Levine, Olivier Glehen
    World Journal of Surgery.2022; 46(6): 1336.     CrossRef
  • New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
    Feng Yin, Zi-Hao Wu, Jin-Ping Lai
    World Journal of Gastroenterology.2022; 28(17): 1751.     CrossRef
  • Goblet Cell Adenocarcinoma of the Appendix: A Systematic Review and Incidence and Survival of 1,225 Cases From an English Cancer Registry
    Kieran Palmer, Scott Weerasuriya, Kandiah Chandrakumaran, Brian Rous, Benjamin E. White, Sangeeta Paisey, Rajaventhan Srirajaskanthan, John K. Ramage
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Current Management of Appendiceal Neoplasms
    Richard S. Hoehn, Caroline J. Rieser, M. Haroon Choudry, Nelya Melnitchouk, Jaclyn Hechtman, Nathan Bahary
    American Society of Clinical Oncology Educational Book.2021; (41): 118.     CrossRef
  • Appendiceal goblet cell carcinomas have poor survival despite completion surgery
    Edward Alabraba, David Mark Pritchard, Rebecca Griffin, Rafael Diaz-Nieto, Melissa Banks, Daniel James Cuthbertson, Stephen Fenwick
    Endocrine.2021; 73(3): 734.     CrossRef
  • Primary adenocarcinoma of the appendix presenting with fresh bleeding per rectum: A case report
    Baijaeek Sain, Arnab Gupta, Samir Bhattacharya, Radha Raman Mondal, Sudip Haldar, Shravasti Roy
    International Journal of Surgery Case Reports.2021; 86: 106285.     CrossRef
  • Omission of Right Hemicolectomy May be Safe for Some Appendiceal Goblet Cell Adenocarcinomas: A Survival Analysis of the National Cancer Database
    Stacy J. Kowalsky, Ibrahim Nassour, Samer AlMasri, Alessandro Paniccia, Amer H. Zureikat, Haroon A. Choudry, James F. Pingpank
    Annals of Surgical Oncology.2021; 28(13): 8916.     CrossRef
  • Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus Surgery Without HIPEC for Goblet-Cell Carcinoids and Mixed Adenoneuroendocrine Carcinomas: Propensity Score–Matched Analysis of Centers in the Netherlands and Belgium
    Nina R. Sluiter, Jarmila D. van der Bilt, Dorothée M.R. Croll, Menno R. Vriens, Ignace H.J.T. de Hingh, Patrick Hemmer, Arend G.J. Aalbers, Andreas J.A. Bremers, Wim Ceelen, Andre D’Hoore, Linda J. Schoonmade, Veerle Coupé, Henk Verheul, Geert Kazemier, J
    Clinical Colorectal Cancer.2020; 19(3): e87.     CrossRef
  • Neuroendocrine tumors of the appendix
    V. S. Trifanov, O. I. Kit, E. N. Kolesnikov, A. V. Snezhko, S. V. Sanamyanz, M. A. Kozhushko, M. Yu. Mesheryakova
    Experimental and Clinical Gastroenterology.2020; 174(5): 82.     CrossRef
  • Survival Profile and Prognostic Factors for Appendiceal Mixed Neuroendocrine Non-neuroendocrine Neoplasms: A SEER Population-Based Study
    Mengzhen Zheng, Tong Li, Yan Li, Tengfei Zhang, Lianfeng Zhang, Wang Ma, Lin Zhou
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Appendiceal neoplasm risk associated with complicated acute appendicitis—a population based study
    Elina Lietzén, Juha M. Grönroos, Jukka-Pekka Mecklin, Ari Leppäniemi, Pia Nordström, Tero Rautio, Tuomo Rantanen, Juhani Sand, Hannu Paajanen, Anne Kaljonen, Paulina Salminen
    International Journal of Colorectal Disease.2019; 34(1): 39.     CrossRef
  • Hypofractionated Stereotactic Radiation Therapy for Metastatic Adenocarcinoma ex Goblet Cell Carcinoid of the Appendix: Case Report and Literature Review
    Joseph W. Clyde, Alan W. Katz
    Case Reports in Oncology.2019; 12(3): 807.     CrossRef
  • Goblet cell carcinoid of the appendix – diagnostic challenges and treatment updates: a case report and review of the literature
    Gregory Gilmore, Kristin Jensen, Shreyas Saligram, Thomas P. Sachdev, Subramanyeswara R. Arekapudi
    Journal of Medical Case Reports.2018;[Epub]     CrossRef
  • Prognostic value of chromogranin A in patients with GET/NEN in the pancreas and the small intestine
    Małgorzata Fuksiewicz, Maria Kowalska, Agnieszka Kolasińska-Ćwikła, Jarosław B Ćwikła, Łukasz Sawicki, Katarzyna Roszkowska-Purska, Joanna Drygiel, Beata Kotowicz
    Endocrine Connections.2018; 7(6): 803.     CrossRef
  • Perforated Goblet Cell Carcinoid Tumors of the Appendix: Navigating the Management Conundrum
    Suman B. Koganti, Brian F. Gilchrist, Tresara C. Bell
    International Surgery.2017; 102(3-4): 131.     CrossRef
  • Appendiceal neuroendocrine neoplasms: diagnosis and management
    Krystallenia I Alexandraki, Gregory A Kaltsas, Simona Grozinsky-Glasberg, Eleftherios Chatzellis, Ashley B Grossman
    Endocrine-Related Cancer.2016; 23(1): R27.     CrossRef
  • Goblet cell carcinoids of the appendix: Tumor biology, mutations and management strategies
    Santosh Shenoy
    World Journal of Gastrointestinal Surgery.2016; 8(10): 660.     CrossRef
  • 14,456 View
  • 168 Download
  • 29 Web of Science
  • 23 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP